Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.
Benderska-Söder N, Hovanec J, Pesch B, Goebell PJ, Roghmann F, Noldus J, Rabinovich J, Wichert K, Gleichenhagen J, Käfferlein HU, Köhler CU, Johnen G, Kernig K, Hakenberg O, Jahn D, Todenhöfer T, Stenzl A, Gleissner J, Gerwert K, El-Mashtoly S, Behrens T, Brüning T, Schmitz-Dräger BJ. Benderska-Söder N, et al. Urol Oncol. 2020 Dec;38(12):886-895. doi: 10.1016/j.urolonc.2020.01.006. Epub 2020 Mar 18. Urol Oncol. 2020. PMID: 32199755 Review.
Eosinophilic cystitis mimicking bladder cancer-considerations on the management based upon a case report and a review of the literature.
Schmitz-Dräger BJ, Skutetzki A, Rieker RJ, Schwab SA, Stöhr R, Bismarck E, Savov O, Ebert T, Benderska-Söder N, Hartmann A. Schmitz-Dräger BJ, et al. Among authors: benderska soder n. Virchows Arch. 2021 Sep;479(3):523-527. doi: 10.1007/s00428-021-03049-x. Epub 2021 Feb 12. Virchows Arch. 2021. PMID: 33576854 Review.
Effectiveness and Distribution of Testosterone Levels within First Year of Androgen Deprivation Therapy in a Real-World Setting: Results from the Non-Interventional German Cohort LEAN Study.
Schmitz-Dräger BJ, Mühlich S, Lange C, Benderska-Söder N, Bismarck E, Starlinger R, Ottillinger B, Hakenberg OW. Schmitz-Dräger BJ, et al. Among authors: benderska soder n. Urol Int. 2021;105(5-6):436-445. doi: 10.1159/000513073. Epub 2021 Feb 25. Urol Int. 2021. PMID: 33631760 Free PMC article.
[Rational follow-up of non-muscle invasive bladder cancer].
von Landenberg N, Benderska-Söder N, Bismarck E, Kernig K, Erne E, Goebell PJ, Schmitz-Dräger BJ. von Landenberg N, et al. Among authors: benderska soder n. Urologe A. 2021 Nov;60(11):1409-1415. doi: 10.1007/s00120-021-01683-6. Epub 2021 Oct 15. Urologe A. 2021. PMID: 34652477 Review. German.
Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria.
Kuckuck EC, Hennenlotter J, Todenhöfer T, Brünn LA, Rass GC, Stenzl A, Hakenberg OW, Roghmann F, Goebell PJ, Grimm MO, Pycha A, Bolenz C, Burger M, Benderska-Söder N, Schmitz-Dräger BJ. Kuckuck EC, et al. Among authors: benderska soder n. Urol Oncol. 2023 May;41(5):254.e1-254.e8. doi: 10.1016/j.urolonc.2022.08.011. Epub 2022 Oct 21. Urol Oncol. 2023. PMID: 36274029
Lifestyle aspects in a contemporary middle-European cohort of patients undergoing androgen deprivation therapy for advanced prostate cancer: data from the non-interventional LEAN study.
Schmitz-Dräger BJ, Bismarck E, Grammenos D, Ebert T, Starlinger R, Ottillinger B, Goebell PJ, Mühlich S, Benderska-Söder N, Hakenberg O. Schmitz-Dräger BJ, et al. Among authors: benderska soder n. Br J Nutr. 2023 Aug 14;130(3):495-502. doi: 10.1017/S0007114522003452. Epub 2022 Nov 10. Br J Nutr. 2023. PMID: 36352765 Free PMC article.
Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer.
Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BWG, Stenzl A, Witjes JA, Todenhöfer T, Hakenberg OW, Grimm MO, Goebell PJ, Burger M, Jensen JB, Schmitz-Dräger BJ. Benderska-Söder N, et al. Urol Oncol. 2024 Feb 24:S1078-1439(24)00041-3. doi: 10.1016/j.urolonc.2024.01.025. Online ahead of print. Urol Oncol. 2024. PMID: 38403529 Review.